Elite Pharmaceuticals, Inc.

ELTP · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$14-$6$17-$11
Dep. & Amort.$0$1$1$0
Deferred Tax$2$5$2$0
Stock-Based Comp.$0$0$0$0
Change in WC$7-$7-$9-$3
Other Non-Cash-$18$22-$7$12
Operating Cash Flow$5$15$4-$1
Investing Activities
PP&E Inv.-$0-$0-$1$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$1$0
Financing Activities
Debt Repay.$0-$4-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0$0
Financing Cash Flow-$0-$4-$0-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$5$10$3-$1
Supplemental Information
Beg. Cash$22$12$9$10
End Cash$27$22$12$9
Free Cash Flow$5$15$3-$1